ArticleMolecules (Basel, Switzerland)2023
Conversion of Methanol to Para-Xylene over ZSM-5 Zeolites Modified by Zinc and Phosphorus.
Article in Molecules (Basel, Switzerland), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
In this work, the influence of different phosphorus sources and the modification of zinc and phosphorus on the performance of the conversion of methanol to aromatics (MTA) was investigated. The results showed that the phosphorus source had a significant impact on the selectivity of para-xylene (PX) in xylene and catalyst stability. The introduction of P resulted in the covering of the active acid sites and the narrowing of the pore of the ZSM-5 zeolite, which improved the shape-selectivity for PX in the methanol conversion reaction. Compared with the modifiers of H
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.